Alexandre Xavier

Callaghan, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Epstein-Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA-DRB1*1501 Risk Variant Share Common Epigenetic Pathways Leading to Multiple Sclerosis Onset.

Epstein-Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA-DRB1*1501 Risk Variant Share Common Epigenetic Pathways Leading to Multiple Sclerosis Onset.

Journal: Annals of neurology

Published: February 10, 2025

HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MS.

HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MS.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: December 27, 2023

DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes.

DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes.

Journal: International journal of molecular sciences

Published: May 22, 2023

p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression.

p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression.

Journal: International journal of molecular sciences

Published: May 12, 2023

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis.

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis.

Journal: Frontiers in immunology

Published: February 10, 2023

Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis.

Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis.

Journal: Neurology

Published: December 08, 2022

Detection of germline variants with pathogenic potential in 48 patients with familial colorectal cancer by using whole exome sequencing.

Detection of germline variants with pathogenic potential in 48 patients with familial colorectal cancer by using whole exome sequencing.

Journal: BMC medical genomics

Published: November 24, 2022

Alteration of DNA Methylation and Epigenetic Scores Associated With Features of Schizophrenia and Common Variant Genetic Risk.

Alteration of DNA Methylation and Epigenetic Scores Associated With Features of Schizophrenia and Common Variant Genetic Risk.

Journal: Biological psychiatry

Published: November 13, 2022

Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity.

Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity.

Journal: Clinical epigenetics

Published: August 08, 2022

Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis.

Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis.

Journal: Clinical epigenetics

Published: April 11, 2022

Epigenome-wide association studies: current knowledge, strategies and recommendations.

Epigenome-wide association studies: current knowledge, strategies and recommendations.

Journal: Clinical epigenetics

Published: May 25, 2021

Exome sequencing of familial adenomatous polyposis-like individuals identifies both known and novel causative genes.

Exome sequencing of familial adenomatous polyposis-like individuals identifies both known and novel causative genes.

Journal: Clinical genetics

Published: April 15, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026